tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CTMX is currently covered by 9 analysts with an average price target of $5.27. This is a potential upside of $3.64 (223.31%) from yesterday's end of day stock price of $1.63.
CytomX Therapeutics's activity chart (see below) currently has 50 price targets and 52 ratings on display. The stock rating distribution of CTMX is 40% BUY, 50% HOLD and 10% SELL.
Analysts average stock forecasts to be materialized ratio is 23.47% with an average time for these price targets to be met of 65.5 days.
Highest price target for CTMX is $3.3, Lowest price target is $3, average price target is $5.27.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 22-Apr-2024.
Currently out of the existing stock ratings of CTMX, 8 are a BUY (40%), 10 are a HOLD (50%), 2 are a SELL (10%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
3 days ago
0/2 (0%)
$7.4 (160.87%)
Buy
3
$1.37 (84.05%)
2
5 months 17 days ago
3/8 (37.5%)
$1.75 (140.00%)
119
Hold
3.3
$1.67 (102.45%)
3.19
5 months 17 days ago
1/9 (11.11%)
$2.05 (164.00%)
56
Hold
2
$0.37 (22.70%)
4
1 years 28 days ago
1/6 (16.67%)
$0.48 (31.58%)
336
Hold
1.75
$0.12 (7.36%)
1.5
1 years 8 months 20 days ago
2/5 (40%)
$0.09 (5.42%)
59
What is CTMX (CytomX Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CTMX (CytomX Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CTMX (CytomX Therapeutics)?
Which analyst is the currently most bullish on CTMX (CytomX Therapeutics)?
Which analyst is the currently most reserved on CTMX (CytomX Therapeutics)?
